(Q83399098)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

title

Formaldehyde-inactivated human enterovirus 71 vaccine is compatible for co-immunization with a commercial pentavalent vaccine (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

author name string

Chun-Wei Chen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Yi-Ping Lee

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Ya-Fang Wang

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

Chun-Keung Yu

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

publication date

11 February 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

issue

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

page(s)

2772-2776

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

Cardiopulmonary manifestations of fulminant enterovirus 71 infection

22 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

An overview of the evolution of enterovirus 71 and its clinical and public health significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Frequent importation of enterovirus 71 from surrounding countries into the local community of Yamagata, Japan, between 1998 and 2003.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Genetic and antigenic analyses of enterovirus 71 isolates in Taiwan during 1998-2005

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Epidemiology of enterovirus 71 in the Netherlands, 1963 to 2008.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

An apparently new enterovirus isolated from patients with disease of the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Enterovirus 71: epidemiology, pathogenesis and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Methylene blue-mediated photodynamic inactivation as a novel disinfectant of enterovirus 71.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Protection against lethal enterovirus 71 infection in newborn mice by passive immunization with subunit VP1 vaccines and inactivated virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Identification of neutralizing linear epitopes from the VP1 capsid protein of Enterovirus 71 using synthetic peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

DNA vaccine constructs against enterovirus 71 elicit immune response in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Immunization with virus-like particles of enterovirus 71 elicits potent immune responses and protects mice against lethal challenge

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Oral immunization of mice using transgenic tomato fruit expressing VP1 protein from enterovirus 71

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

New generation of inactivated poliovirus vaccines for universal immunization after eradication of poliomyelitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Long-term circulation of vaccine-derived poliovirus that causes paralytic disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Development of enterovirus 71 vaccines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

A rapid, simple, and humane method for submandibular bleeding of mice using a lancet.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Enterovirus 71 Infection of Monocytes with Antibody-Dependent Enhancement

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Role of recombination in evolution of enteroviruses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Intertypic cross-neutralization of polioviruses by human monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Evolutionary genetics of human enterovirus 71: origin, population dynamics, natural selection, and seasonal periodicity of the VP1 gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

An attenuated strain of enterovirus 71 belonging to genotype a showed a broad spectrum of antigenicity with attenuated neurovirulence in cynomolgus monkeys.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Cross-antigenicity among EV71 strains from different genogroups isolated in Yamagata, Japan, between 1990 and 2007.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

Evolutionary trajectory of the VP1 gene of human enterovirus 71 genogroup B and C viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.01.094

10.1016/J.VACCINE.2011.01.094

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21315698%20AND%20SRC:MED&resulttype=core&format=json

22 January 2020

1 reference